For example, the NOS inhibitor L-NAME is shown to increase the predominance of sympathetic measures of blood pressure variability and baroreceptor reflex sensitivity and higher plasma NO levels are reported in heart failure patients than in control subjects [41]. Here, NOS1 is linked to heart failure.